Besides these global chromatin effects related to HMT activity, it has been demonstrated in other cancer types that NSD1 regulates additional oncogenic signaling pathways, such as Nuclear Factor-kappa B (NF-κB) (14), Wnt/β-catenin (15, 16), and HIF1α (17). This evidence concerns the gene NSD1 and cancer.